James Hinchberger

James Hinchberger has significant experience in the pharmaceutical and healthcare industries, with a focus on access and reimbursement management. Currently serving as a Field Access and Reimbursement Manager at Apellis Pharmaceuticals since August 2022, James provides support for a groundbreaking treatment for Geographic Atrophy associated with Age-Related Macular Degeneration. Previously, at Flexion Therapeutics, James prioritized appeals and reimbursement challenges across seven states. Other roles include Senior Specialty Account Manager at Allergan, where James contributed to launching a biodegradable implant for glaucoma, and various managerial positions at Auxilium Pharmaceuticals, where James achieved notable sales success and trained sales teams. An educational background includes a Bachelor of Arts in Liberal Sciences from Barry University and an MBA from Tulane University's A.B. Freeman School of Business.